Mayo Clinic Inflammatory Bowel Disease Repository

Overview

About this study

The purpose of this research study is to collect clinical information and human samples from patients with IBD. The data collected will be used to create an organized, accessible resource of human samples for biological research in IBD.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Adult

  • Patients at ages 18 to 99 years old.
  • Individuals diagnosed with IBD using standard clinical, endoscopic, radiological and histological criteria.
  • Individuals without IBD: these individuals may include ethnically, gender and/or age matched control subjects; or environmental controls with no known personal or family history of IBD (may include eligible spouses and friends of study patients with IBD).
  • Family members of individuals with IBD.
  • Patients undergoing gastrointestinal surgery at Mayo Clinic for IBD or non-IBD indications.
  • Patients with or without IBD having lower GI endoscopic procedures for routine care at Mayo Clinic.
  • Patients being seen in the Gastroenterology and Hepatology Department for other gastroenterology and hepatology conditions
  • Venipuncture is feasible (health, access and/or tolerability) for requested blood sample(s).
  • Individuals have agreed to participate and signed the study informed consent form.

Children with IBD

  • Patients at ages 0 to 17 years old.
  • Individuals diagnosed with IBD using standard clinical, endoscopic, radiological and histological criteria.
  • Patients undergoing gastrointestinal surgery at Mayo Clinic for IBD.
  • Patients with IBD having lower GI endoscopic procedures for routine care at Mayo Clinic.
  • Venipuncture is feasible (health, access and/or tolerability) for requested blood sample(s).
  • Individuals have agreed to participate and signed the study informed consent form.

Children without IBD

  • Patients at ages 0 to 17 years old.
  • Individuals without IBD: these individuals may include ethnically, gender and/or age matched control subjects; or environmental controls with no known personal or family history of IBD (may include eligible spouses and friends of study patients with IBD).
  • Venipuncture is feasible (health, access and/or tolerability) for requested blood sample(s).
  • Individuals have agreed to participate and signed the study informed consent form.

Exclusion Criteria:

Adults

  • Individuals who do not meet study inclusion criteria.
  • Individuals who have not agreed to participate and have not signed the study consent form.

Children with IBD

  • Individuals who do not meet study inclusion criteria.
  • Individuals who have not agreed to participate and have not signed the study consent form.

Children without IBD

  • Individuals who do not meet study inclusion criteria.
  • Individuals who have not agreed to participate and have not signed the study consent form.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Michael Picco, M.D., Ph.D.

Open for enrollment

Contact information:

Adrienne Graham M.P.H.

(904)953-3726

Graham.Adrienne@mayo.edu

Rochester, Minn.

Mayo Clinic principal investigator

William Faubion, M.D.

Open for enrollment

Contact information:

Erin Kammer

(507)538-0678

Kammer.Erin@mayo.edu

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Shabana Pasha, M.D.

Open for enrollment

Contact information:

Rachel Kendrick

(480)301-6767

Kendrick.Rachel@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20424743

Mayo Clinic Footer